Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts
暂无分享,去创建一个
R Somorjai | A. Steinhart | R. Somorjai | B. Levin | B. Dolenko | D. Rubin | C. Bernstein | T. Bezabeh | I. Smith | E. Jeyarajah | A. Steinhart | C N Bernstein | B Levin | T Bezabeh | B Dolenko | N Bryskina | E Jeyarajah | A H Steinhart | D T Rubin | I C P Smith | B. Dolenko | N. Bryskina | C. Bernstein | I. Smith | D. Rubin
[1] B. Vogelstein,et al. Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.
[2] R L Somorjai,et al. Nonlinear methods for discrimination and their application to classification of protein structures. , 1988, Journal of theoretical biology.
[3] D. Eddy,et al. Screening for colorectal cancer , 1992, The Lancet.
[4] P. Nair,et al. Human stools as a source of viable colonic epithelial cells , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] W. Mackinnon,et al. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. , 1992, Biochemistry.
[6] A. Okada,et al. Increased aspartate and glutamate levels in both gastric and colon cancer tissues. , 1993, The Tokushima journal of experimental medicine.
[7] Peter Russell,et al. Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms , 1995, Magnetic resonance in medicine.
[8] D Fewer,et al. Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy , 1996, Journal of magnetic resonance imaging : JMRI.
[9] R. Somorjai,et al. Diagnostic potential for cancer via 1H magnetic resonance spectroscopy of colon tissue. , 1996, Anticancer research.
[10] R. Somorjai,et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis , 1997, Magnetic resonance in medicine.
[11] D. Rex,et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.
[12] R L Somorjai,et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.
[13] D. Ransohoff,et al. CLINICAL GUIDELINE: PART II: Screening for Colorectal Cancer with the Fecal Occult Blood Test: A Background Paper , 1997, Annals of Internal Medicine.
[14] R L Somorjai,et al. Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.
[15] T. Church,et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.
[16] S. Thibodeau,et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.
[17] C E Mountford,et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine‐needle aspirates analysed using a statistical classification strategy , 2001, The British journal of surgery.
[18] R L Somorjai,et al. Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. , 2001, International journal of radiation oncology, biology, physics.
[19] R. Somorjai,et al. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease , 2001 .
[20] S. Goodman,et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. , 2001, Journal of the National Cancer Institute.
[21] R. Somorjai,et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region , 2002, Head & neck.
[22] Ray L. Somorjai,et al. Accurate diagnosis and prognosis of human cancers by proton MRS and a three-stage classification strategy , 2002 .
[23] P. Pickhardt,et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. , 2003, The New England journal of medicine.
[24] Uwe Himmelreich,et al. Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy. , 2003, American journal of surgery.
[25] I. Smith,et al. Medical Diagnosis by High Resolution NMR of Human Specimens , 2003, IUBMB life.
[26] B. Levin,et al. Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.
[27] D. Ransohoff,et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.
[28] M. Widschwendter,et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? , 2004, The Lancet.
[29] J. Burdick,et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. , 2004, JAMA.
[30] D. Ahlquist,et al. Stool screening for colorectal cancer: molecular approaches. , 2005, Gastroenterology.
[31] C. Mountford,et al. Proton spectroscopy provides accurate pathology on biopsy and in vivo , 2006, Journal of magnetic resonance imaging : JMRI.
[32] N. Serkova,et al. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics , 2006, Expert review of molecular diagnostics.
[33] I. Wilson,et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.
[34] Kirill Veselkov,et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. , 2008, Journal of proteome research.